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Abstract
Transmissible gastroenteritis coronavirus (TGEV) contains eight overlapping genes that are expressed from a 3-coterminal nested set
of leader-containing mRNAs. To facilitate the genetic manipulation of the viral genome, genes were separated by duplication of transcription
regulating sequences (TRSs) and introduction of unique restriction endonuclease sites at the 5 end of each gene using an infectious cDNA
clone. The recombinant TGEV (rTGEV) replicated in cell culture with similar efficiency to the wild-type virus and stably maintained the
modifications introduced into the genome. In contrast, the rTGEV replication level in the lungs and gut of infected piglets and virulence
were significantly reduced. rTGEV in which gene 7 expression was abrogated (rTGEV-7) were recovered from cDNA constructs,
indicating that TGEV gene 7 was a nonessential gene for virus replication. Interestingly, in vivo infections with rTGEV-7 showed an
additional reduction in virus replication in the lung and gut, and in virulence, indicating that TGEV gene 7 influences virus pathogenesis.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Transmissible gastroenteritis coronavirus (TGEV) is a
member of the Coronaviridae family, which, together with
the Arteriviridae and Roniviridae families forms the Nidovi-
rales order (Cowley and Walker, 2002; Enjuanes et al.,
2000a; Mayo, 2002). TGEV replicates in both the villous
epithelial cells of the small intestine and the lung cells of
newborn piglets, resulting in a mortality of nearly 100%
(Saif and Wesley, 1992). The TGEV genome contains a
leader sequence at the 5 end and a poly(A) tail at the 3 end.
Genes are arranged in the order 5-Rep-S-3a-3b-E-M-N-
7-3 (Enjuanes et al., 2000b; Penzes et al., 2001). The 3 end
of the majority of TGEV genes overlaps with the 5 termi-
nus of the next gene (Enjuanes et al., 2000b), complicating
insertion of heterologous genes into the viral genome and
deletion of different genes to determine whether they are
essential.
The TGEV gene 7, located at the 3 end of the genome,
encodes a 78 amino acid hydrophobic protein that may play
a role in membrane-associated replication complexes or in
virion assembly (Tung et al., 1992). Gene 7 is a group-
specific gene (de Haan et al., 2002) with homologous ver-
sions in group 1 coronaviruses such as feline infectious
peritonitis virus (FCoV) and canine enteric coronavirus
(CCoV) (Enjuanes et al., 2000a; Lai and Cavanagh, 1997).
In contrast, group 2 coronaviruses such as mouse hepatitis
virus (MHV), bovine enteric coronavirus (BCoV), or the
human coronavirus (HCoV) OC43, and group 3 coronavi-
ruses such as avian infectious bronchitis virus (IBV), do not
have a homologous gene 7 (Enjuanes et al., 2000a; Lai and
Cavanagh, 1997). Interestingly, the group 1 coronavirus
HCoV-229E does not have gene 7 (Herold et al., 1993),
which could indicate that this gene is nonessential for coro-
navirus replication, even in group 1 coronaviruses.
To study whether gene 7 is dispensable for TGEV rep-
lication, its deletion by reverse genetics would be required.
We used a genomic TGEV cDNA clone assembled as a
bacterial artificial chromosome (BAC) (Almaza´n et al.,
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2000; Gonza´lez et al., 2002) to separate the overlapping
genes by duplicating sequences at the 5 flank of each gene
and by introducing unique restriction endonuclease sites
between each gene pair. Gene separation allowed the dele-
tion of gene 7, showing that it is nonessential for virus
replication. Furthermore, we show that the accumulation of
modifications in gene domains where the TRSs are located
and insertion of restriction sites led to the generation of a
collection of recombinant TGEVs (rTGEVs) with variable
virulence, including a highly attenuated recombinant. These
viruses could be the basis for coronavirus vector develop-
ment.
Results
Generation of rTGEV viruses with nonoverlapping genes
separated by unique restriction endonuclease sites
To facilitate genetic manipulation of the viral genome,
full-length cDNA clones were constructed by separating the
contiguous genes and inserting unique restriction sites be-
tween each gene pair (Fig. 1A). cDNA clones with the
wild-type sequence or containing one [pBAC-TGEV-PacI
(P), pBAC-TGEV-MluI (M), pBAC-TGEV-FseI (F), and
pBAC-TGEV-AscI (A)], two [pBAC-TGEV-FseI-PmeI (F-
Pm), pBAC-TGEV-PmeI-AscI (Pm-A), and pBAC-TGEV-
PacI-MluI (P-M)], three [pBAC-TGEV-FseI-PmeI-AscI (F-
Pm-A)], or five [pBAC-TGEV-PacI-MluI-FseI-PmeI-AscI
(RS)] restriction endonuclease sites (Fig. 1B) were trans-
fected into BHK cells expressing the porcine amino pepti-
dase N (pAPN) (BHK-pAPN cells). On the third day of
transfection, a cytopathic effect was observed in cells trans-
fected with each cDNA, but not in mock-treated cells. Virus
production was amplified by passing the supernatants four
times in cultured cells. After the fourth passage, viruses
were cloned by three plaque-isolation steps, and their ge-
nomes were partially sequenced. All the rTGEV viruses
conserved the modifications engineered in the cDNAs (data
not shown), indicating that the ORF separation and the
insertion of unique endonuclease restriction sites between
genes were stably maintained in the rTGEV genomes.
Cloned rTGEV viruses containing the unique restriction
sites showed similar growth kinetics in cell culture to the
parental rTGEV-wt after infection at both low (0.05) and
high (5) m.o.i. (Fig. 2), indicating that removal of the
overlapping region between TGEV genes and the insertion
of endonuclease restriction sites did not significantly affect
the in vitro virus replication.
Rescue of infectious rTGEV-7 virus from the cDNA
To analyze whether gene 7 was essential for viral
growth, recombinant virus genomes with gene 7 deleted
were generated from pBAC-TGEV-RS constructs, contain-
ing either the S gene from the TGEV strain PUR-C11
(Sa´nchez et al., 1999) able to infect both the enteric and the
respiratory tracts (pBAC-TGEV-SC11-RS-7) or the S gene
from the strain PTV (Sa´nchez et al., 1999) with an exclusive
respiratory tropism (pBAC-TGEV-SPTV-RS-7). The
rTGEV-7 contained a deletion spanning 21 nucleotides
upstream of the ORF 7 AUG and the first 17 nucleotides of
this ORF (Fig. 3A). BHK-pAPN cells were transfected with
plasmids including five restriction endonuclease sites and
carrying gene 7 (pBAC-TGEV-SPTV-RS and pBAC-TGEV-
SC11-RS), or without this gene (pBAC-TGEV-SPTV-RS-7
and pBAC-TGEV-SC11-RS-7). Virus titers were deter-
mined in supernatants throughout four additional passages
in cell culture (Fig. 3B and C). Viruses were recovered from
the cDNAs containing the deletion of gene 7, and viral titers
increased with passage, basically to the same extent as the
viruses with gene 7 (rTGEV-SPTV-RS and rTGEV-SC11-RS).
As expected, no virus was recovered from the mock-trans-
fected cultures.
After four passages in cell cultures, the recombinant
viruses were cloned by three plaque isolation steps. The
cytopathic effect and plaque morphology produced by the
rTGEV-SPTV-RS-7 and rTGEV-SC11-RS-7 were identical
to those of the parental viruses containing the complete
genome (data not shown). The isolate rTGEV-SC11-RS-7
induced the formation of large-size plaques (3-mm-diame-
ter), whereas the virus rTGEV-SPTV-RS-7 induced small-
sized plaques (1-mm-diameter). The cloned viruses with
gene 7 deleted showed standard growth kinetics after infec-
tion at an m.o.i. of 5 (Fig. 3D and E). Recombinant rTGEV-
SPTV-RS-7 and rTGEV-SC11-RS-7 generated the highest
virus titers (around 6  108 and 107 PFU/ml, respectively)
at 24 h postinfection, similar to those of the parental viruses
rTGEV-SPTV-RS and rTGEV-SC11-RS. These data indicated
that the protein encoded by gene 7 was not essential for
TGEV replication in cell culture.
To confirm that the subgenomic mRNA (sgmRNA) 7
was not transcribed, BHK-pAPN cells were infected with
rTGEV-SPTV-RS or rTGEV-SPTV-RS-7 viruses. Total
RNA was extracted and analyzed by Northern blot with a
probe complementary to the 3 end of the TGEV genome
(Fig. 4A). The mobility and relative amount of the
sgmRNAs 2, 3, 4, 5, and 6 were indistinguishable in both
viruses. As expected, sgmRNA 7 was transcribed in rT-
GEV-SPTV-RS-infected cells, but not in cells infected with
rTGEV-SPTV-RS-7. Analysis of viral proteins at 16 h p.i.
by Western blot showed that the amount of S, N, M, and E
proteins was similar in rTGEV-SPTV-RS-7-infected cells
and in cells infected with the parental virus rTGEV-SPTV-
RS, except for protein 7 that was not detected in rTGEV-
SPTV-RS-7 virus-infected cells (Fig. 4B), confirming that
the partial deletion of gene 7 prevented the synthesis of
protein 7. Identical results were obtained with rTGEV-
SC11-RS and rTGEV-SC11-RS-7 (data not shown).
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Replication of rTGEV-RS and rTGEV-RS-7 viruses in
swine
In vivo growth of a selected set of rTGEVs containing
the unique endonuclease restriction sites, and the rTGEV-
RS-7 viruses, was determined by infecting newborn pig-
lets. The animals were sacrificed at 1, 2, 3, and 4 days p.i.
Recombinant viruses with a modification including a re-
striction endonuclease site 5 upstream of some genes, in
general, showed lower titers than the wild-type virus, al-
Fig. 1. Scheme of the strategy used to separate TGEV overlapping genes. (A) Structure of the 5 end of TGEV genes after gene separation by duplication
of sequences partially overlapping with the transcription-regulating sequences and introduction of unique restriction sites. Unique endonuclease restriction
sites are indicated in italics. Outlined sequences indicate the punctual mutations introduced to generate unique restriction sites. The core sequence (CS) is
underlined. The ATG start codon is shown in bold. Duplicated sequences are indicated by dark boxes. TGEV genes are indicated by light boxes. 1b, replicase
1b gene; S, spike gene; E, envelope gene; M, membrane gene; N, nucleoprotein gene. *, Gene Rep 1b termination codon (TGA) and the initiation codon of
gene S (ATG) partially overlap. The sequence of the 24 and 83 nt located 5 upstream of genes S and 3a, respectively, are described in the full-length TGEV
genome sequence previously reported (Penzes et al., 2001). (B) Schematic illustration of the full-length TGEV cDNA without (top bar) or with one
(pBAC-TGEV-P, pBAC-TGEV-M, pBAC-TGEV-F, and pBAC-TGEV-A), two (pBAC-TGEV-F-Pm, pBAC-TGEV-Pm-A, and pBAC-TGEV-P-M), three
(pBAC-TGEV-F-Pm-A), or five (pBAC-TGEV-RS) restriction endonuclease sites. CMV, cytomegalovirus immediate-early promoter; Rep, replicase; An,
poly(A) tail of 24 A residues; HDV, hepatitis delta virus ribozyme; BGH, bovine growth hormone termination and polyadenylation sequences.
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though there was some titer variability over the 4 days
postinfection (Fig. 5A and B). Alteration in domains 5
upstream of two or more genes did not lead to a significant
decrease in virus titer in comparison with recombinants with
a single modification.
Interestingly, analysis of viral growth in the gut of in-
fected piglets showed a 100- to 5000-fold reduction of
recombinant viruses containing one or more restriction sites
in relation to the rTGEV-wt virus (Fig. 5D and E). The
rTGEV-RS, that included modifications 5 upstream of five
Fig. 2. Growth kinetics of rTGEV viruses in cell culture. Growth kinetics of TGEV-wt, TGEV-F, TGEV-A, TGEV-P, TGEV-M, TGEV-P-M, TGEV-F-A,
TGEV-F-Pm, TGEV-F-Pm-A, and TGEV-RS in BHK-pAPN cells after infection at low (0.05) and high (5) multiplicities of infection. Mean values of three
experiments are indicated.
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genes and insertion of endonuclease restriction sites be-
tween each contiguous gene, showed a titer decrease com-
parable with that of rTGEVs with two (TGEV-F-A) or three
(TGEV-F-Pm-A) restriction endonuclease sites. These data
show that modification of sequences 5 upstream of genes
affected virus replication in the gut. Recombinant viruses
were isolated from the gut and sequenced. All the modifi-
cations introduced were stably maintained in the TGEV
genome during in vivo infections (data not shown).
The growth in lungs of gene 7 deletion mutants (rTGEV-
SPTV-RS-7 and rTGEV-SC11-RS 7) showed around 100-
fold reduction of virus titers compared with the parental
viruses rTGEVSPTV-RS and rTGEV-SC11-RS (Fig. 5C). In
contrast, in vivo growth of rTGEV-SC11-RS-7 in the gut
Fig. 3. Rescue and growth kinetics of rTGEV-7 from cDNA in BHK-pAPN cells. (A) Scheme of pBAC-TGEV-RS-7 coding for rTGEV-RS-7 virus. The
deletion 7 virus that includes 21 nt of TRS-7 and the first 17 nt of ORF-7 (outlined letters) is underlined. The core sequence is shown in bold. Acronyms
as in Fig 1. (B) and (C) Virus titers of TGEV-SPTV-RS and TGEV-SPTV-RS-7 (B) and TGEV-SC11-RS and TGEV-SC11-RS-7 (C) recovered from
BHK-pAPN cells transfected with plasmids pBAC-TGEV-SPTV-RS, pBAC-TGEV-SPTV-RS-7, pBAC-TGEV-SC11-RS, and pBAC-TGEV-SC11-RS-7,
respectively. The recovered virus was amplified throughout the indicated passages, and the culture supernatants were titrated on ST cells. Mock, mock
transfected cells. (D) and (E) Growth kinetics of cloned TGEV-SPTV-RS-7 (D) and TGEV-SC11-RS-7 (E) in cell culture, after infection at an m.o.i. of 5.
Aliquots were collected at the indicated times and titrated on ST cells. Error bars represent standard deviations of the mean from four experiments.
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showed slightly lower replication levels than rTGEV-
SC11-RS (5  104 PFU/g) probably because the introduction
of modifications at the 5 upstream of five genes had already
caused a significant titer reduction (Fig. 5F). As expected,
the respiratory recombinants rTGEV-SPTV-RS and rTGEV-
SPTV-RS-7 did not grow in the gut since the S gene was
derived from the respiratory PTV strain.
Piglet survival after infection by rTGEV viruses was
compared with survival after infection with their virulent
parental virus TGEV-PUR46-C11 (TGEV-SC11-wt). rTGEV
viruses with one, two, three, or five unique restriction sites
were highly attenuated (they produced mild enteritis and led
to 80 to 90% survival at 5 days p.i.), except for rTGEV-P
and rTGEV-M viruses, in which the restriction sites PacI
and MluI were introduced by point mutations, without in-
troducing TRS duplication. In these two recombinant vi-
ruses the survival was from 0 to 20%. Piglets infected by
rTGEV-SC11-RS-7 showed 100% survival, although a very
mild and transitory enteritis was observed in 50% of the
animals. These data indicate that gene 7 deletion further
reduced virus virulence. In general, a good correlation be-
tween growth of recombinants with a single restriction en-
donuclease insertion and virulence was not clear. This could
be due to differences in the distribution of viral antigens and
inflammatory responses in pigs infected with wild-type or
each mutant. Nevertheless, in viruses with two or more
restriction endonuclease sites inserted there was a good
correlation between virus titers in the gut and mortality.
Discussion
TGEV genomes with all the genes separated by unique
endonuclease restriction sites have been engineered. The
separation of TGEV genes implied the duplication of se-
quences 5 upstream of each gene, a sequence domain
involved in regulating transcription, and affected in vivo
virus growth and virulence. In this article, the first demon-
stration that TGEV gene 7 is nonessential for virus viability
is provided. In addition, it has been demonstrated that gene
7 deletion affects TGEV replication and attenuates virus
virulence in piglets, its natural host. Interestingly, the intro-
Fig. 5. In vivo growth kinetics of rTGEV viruses. Two- to three-day-old non-colostrum-deprived swine were used to study the growth kinetics of rTGEV
viruses containing one (A and D) or more (B and E) endonuclease restriction sites, or partial deletion of gene 7 (C and F). Groups of 12 to 20 piglets were
oronasally (2 108 PFU/pig) and intragastrically (3 108 PFU/pig) inoculated. Virus titers at the indicated number of days postinoculation were determined
in the indicated tissue extracts. The whole organs were homogenized to obtain representative samples. Error bars represent standard deviations of the mean
from four experiments. (G) Number of surviving piglets at different days postinoculation. Results from a representative experiment of two that gave similar
results are shown. Recombinant virus titers were compared with that of the wild-type virus by the Kruskal–Wallis test and, in general, were significant (P
 0.05) between viruses with gene 7 deleted and the wild-type virus.
Fig. 4. Characterization of mRNAs and proteins of rTGEV-7. (A) Northern blot analysis of viral mRNAs. Total RNA was isolated from BHK-pAPN cells
infected with either rTGEVSPTV-RS or rTGEV-SPTV-RS-7. V, noninfected BHK-pAPN cells. The position of viral mRNAs is indicated to the left. (B)
Western blot analysis of lysates from BHK-pAPN cells infected with either rTGEV-SPTV-RS or rTGEV-SPTV-RS-7 viruses. Cell extracts were obtained at
16 h p.i., resolved by 5 to 20% gradient SDS–PAGE, transferred to nitrocellulose membranes, and immunoblotted with monoclonal antibodies specific for
S, N, M, and E, and with an antiserum specific for a protein 7 peptide (Garwes et al., 1989).
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duction of one or more modifications into the TGEV ge-
nome has led to the generation of a collection of TGEV
recombinants with a variable degree of virulence.
Overlapping of genes has been proposed as a mechanism
by which nidoviruses preserve the genetic integrity of vital
parts of their genomes (de Vries et al., 2000). Nevertheless,
in coronavirus we have generated viable and stable rTGEV
viruses in which genes have been separated by the insertion
of unique restriction endonuclease sites and modification of
the domains where the transcription-regulating sequences
(TRSs) map. Maximum titers of mutant rTGEV viruses in
cell culture were similar to those obtained for the parental
virus, indicating that changes in the sequences between
TGEV genes had little effect on viral yield. In contrast, in
vivo assays showed lower TGEV mutant virus replication in
the lungs and gut, and attenuation of virulence in viruses in
which a TRS duplication was introduced between genes. In
arteriviruses, mutants that had the overlap between ORFs 4
and 5, or between ORFs 5 and 6 removed, were also viable
(de Vries et al., 2000). Taken together, these data demon-
strate that gene overlapping is not an obligatory requirement
for Nidovirales viability.
Viral attenuation resulting from gene separation was
possibly due to modification of the TRSs affecting mRNA
transcription levels. In the case of nonsegmented negative-
strand RNA viruses it has also been shown that sequence
alterations, such as restriction endonuclease site or heterol-
ogous gene insertion, and gene rearrangement may affect
virus replication (Wertz et al., 2002).
Gene 7 is a group 1 specific gene, absent in genome of
coronaviruses from groups 2 and 3 (Armstrong et al., 1983;
Boursnell et al., 1985; Kamahora et al., 1989; Lapps et al.,
1987; Skinner and Siddell, 1985). Interestingly, no mortal-
ity was observed in piglets infected with rTGEV-7. Since
these recombinants still replicate with titers between 103
and 105 PFU/g of tissue (Fig. 5C and F), TGEV-7 mutants
could be good candidates as virus vectors.
A relationship between gene 7 and virulence has also
been observed in the FCoVs. The most 3 end genes of these
viruses are genes 7a and 7b. Deletions in FCoV ORF 7a,
which is homologous to the TGEV ORF 7, have been
reported in a natural infection of a cat population and
correlated with a decrease in virulence (Kennedy et al.,
2001). Similarly, mutations in FCoV ORF 7b occur in vitro
and have also been correlated with loss of virus virulence
(Herrewegh et al., 1995). Therefore, the most 3 end genes
of group 1 coronaviruses seem to influence in general virus
pathogenesis.
Deletion of gene 7 did not affect virus replication in cell
culture. Therefore, the reduction of in vivo virus replication
and virulence was probably due to an effect on virus–host
interaction. It has been suggested that coronavirus group-
specific genes, such as gene 7, may affect host immune
response (de Haan et al., 2002). It would be of interest to
determine whether the immune response to a heterologous
gene inserted in recombinant viruses with and without gene
7 is influenced by the presence of this gene.
In an attempt to identify gene 7 homologous protein
sequences or motifs, a sequence search was performed in
the databases using gene 7 sequences without success. The
high hydrophobicity of TGEV protein 7 (Garwes et al.,
1989) could facilitate its insertion in membranes providing
a role in virus replication, since coronavirus replication
complexes have been associated with membranes (Denni-
son and Sims, 2001; Snijder et al., 2001). Similarly, the
tentative location of protein 7 within the nucleus (Garwes et
al., 1989) could be taken as an indication for a possible
interference with the cell cycle, similarly to coronavirus
nucleoprotein that seems to interact with cell nucleolus
proteins and interfere with cell cycle (Hiscox, 2002).
Therefore, genes 3a, 3b, and 7 of group 1 coronaviruses
are nonessential for replication. Similarly, genes 2a/HE and
4/5a, and possibly gene E, are dispensable in MHV (de
Haan et al., 2002; Kuo and Masters, 2002). Manipulation of
transcription-regulating sequences and deletion of nones-
sential genes, such as gene 7, will facilitate the study of the
molecular basis of viral attenuation and provide an attrac-
tive approach to generate attenuated rTGEVs with high
potential as virus vectors.
Materials and methods
Virus and cells
Baby hamster kidney cells (BHK-21) stably transformed
with the gene coding for the porcine aminopeptidase N
(BHK-pAPN) (Delmas et al., 1994) were grown in DMEM
supplemented with 2% fetal calf serum and Geneticin G418
(1.5 mg/ml) as a selection agent. BHK-pAPN cells were
used for all the experiments except for standard virus titra-
tions that were performed in porcine swine testis (ST) cells
(McClurkin and Norman, 1966).
Virus titers were compared by the Kruskal–Wallis test
(Motulsky, 1995) and, when significant (P  0.05), it was
indicated. rTGEV viruses were generated from pBAC-
TGEV constructs containing the S gene from the virulent
TGEV strain PUR-C11 (SC11) as described (Almaza´n et al.,
2000; Gonzalez et al. 2002). Viruses containing the S gene
from the attenuated strain PTV (SPTV) were derived from
the corresponding pBAC TGEV vectors with gene SC11 by
replacing this gene by that (SPTV) of the respiratory strain.
Construction of modified rTGEV genomes
Two different approaches were followed to introduce
into pBAC-TGEV unique restriction endonuclease sites
separating each gene of TGEV genome (Fig. 1A), leading to
pBAC-TGEV-RS. The first approach was the introduction
of punctual mutations in the TGEV genome to generate the
restriction sites PacI (between genes Rep 1b and S) and
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MluI (between genes S and 3a) (Fig. 1B). Due to overlap-
ping in the TGEV genome, the second approach involved
the duplication of 13, 22, and 19 nucleotides from the 5
transcription-regulating sequences of genes M, N, and 7
(TRS-M, TRS-N, and TRS-7) after the restriction sites FseI,
PmeI, and AscI, respectively (Fig. 1A and B). Point muta-
tions, duplications, and insertion of restriction endonuclease
sites were generated by overlapping PCR amplification
from the TGEV genome as described (Ortego et al., 2002).
The assembly of the full-length pBAC-TGEV constructs
was performed as previously reported (Almaza´n et al.,
2000; Gonza´lez et al., 2002).
To generate the deletion 7, oligonucleotide primers
5-Asc-7.17-VS (5-GAGGCGCGCCTGCTGTATTTAT-
TACAG-3), including the restriction site AscI (underlined)
and the deletion of 21 nucleotides from TRS-7 plus the first
17 nucleotides of ORF 7, and BGH34-RS (5-CAGATG-
GCTGGCAACTAGAAGGC-3) were used to generate a
PCR product comprising from nt 28,094 to nt 28,764 of the
TGEV cDNA clone. PCR product was digested with AscI
and BamHI and cloned into the AscI-BamHI-digested
pBAC-TGEV-SC11-RS and pBAC-TGEV-SPTV-RS, generat-
ing pBAC-TGEV-SC11-RS-7 and pBAC-TGEV-SPTV-RS-
7, respectively.
Transfection and recovery of infectious TGEV from cDNA
clones
BHK-pAPN cells were grown to 60% confluence on
35-mm-diameter plates and transfected with 10 g of
cDNA plasmid and 15 g of Lipofectin (Life Technologies,
GIBCO) according to the manufacturer’s specifications. Re-
covery and amplification of viruses were performed as de-
scribed (Ortego et al., 2002).
Western and Northern blot analysis
Cell lysates were analyzed by 5 to 20% gradient sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE). Proteins were transferred to a nitrocellulose mem-
brane and analyzed as described (Ortego et al., 2002), using
mAbs specific for S (5B.H1), N (3D.C10), M (9D.B4), and
E (V27) proteins (Ortego et al., 2002), and a swine poly-
clonal antibody specific for TGEV protein 7 (provided by P.
Britton, Compton, UK). Total RNA was extracted by using
an Ultraspec RNA isolation system (Biotecx) according to
the manufacturer’s instructions and analyzed by Northern
blotting as described (Ortego et al., 2002).
In vivo growth kinetics of rTGEV viruses
Two- to three-day-old non-colostrum-deprived swine,
from crossing Large White and Belgium Landrace, were
used to study in vivo growth kinetics of rTGEV, as de-
scribed (Sanchez et al., 1999). Piglets were obtained from
sows seronegative for TGEV, as tested by radioimmunoas-
say.
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